JP2013501796A5 - - Google Patents

Download PDF

Info

Publication number
JP2013501796A5
JP2013501796A5 JP2012524789A JP2012524789A JP2013501796A5 JP 2013501796 A5 JP2013501796 A5 JP 2013501796A5 JP 2012524789 A JP2012524789 A JP 2012524789A JP 2012524789 A JP2012524789 A JP 2012524789A JP 2013501796 A5 JP2013501796 A5 JP 2013501796A5
Authority
JP
Japan
Prior art keywords
delivery device
drug delivery
subject
migraine
score
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012524789A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013501796A (ja
JP6116246B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/045045 external-priority patent/WO2011019732A1/en
Publication of JP2013501796A publication Critical patent/JP2013501796A/ja
Publication of JP2013501796A5 publication Critical patent/JP2013501796A5/ja
Application granted granted Critical
Publication of JP6116246B2 publication Critical patent/JP6116246B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012524789A 2009-08-10 2010-08-10 イオントフォレシスにより悪心および片頭痛を治療するための方法 Active JP6116246B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US23261709P 2009-08-10 2009-08-10
US61/232,617 2009-08-10
US25679609P 2009-10-30 2009-10-30
US61/256,796 2009-10-30
US35830010P 2010-06-24 2010-06-24
US61/358,300 2010-06-24
PCT/US2010/045045 WO2011019732A1 (en) 2009-08-10 2010-08-10 Methods for iontophoretically treating nausea and migraine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015150968A Division JP2016014028A (ja) 2009-08-10 2015-07-30 イオントフォレシスにより悪心および片頭痛を治療するための方法

Publications (3)

Publication Number Publication Date
JP2013501796A JP2013501796A (ja) 2013-01-17
JP2013501796A5 true JP2013501796A5 (enExample) 2013-09-19
JP6116246B2 JP6116246B2 (ja) 2017-04-19

Family

ID=43586432

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012524789A Active JP6116246B2 (ja) 2009-08-10 2010-08-10 イオントフォレシスにより悪心および片頭痛を治療するための方法
JP2015150968A Pending JP2016014028A (ja) 2009-08-10 2015-07-30 イオントフォレシスにより悪心および片頭痛を治療するための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015150968A Pending JP2016014028A (ja) 2009-08-10 2015-07-30 イオントフォレシスにより悪心および片頭痛を治療するための方法

Country Status (11)

Country Link
US (2) US8845612B2 (enExample)
EP (1) EP2464234A4 (enExample)
JP (2) JP6116246B2 (enExample)
CN (3) CN105748401A (enExample)
AU (1) AU2010282660B2 (enExample)
BR (1) BR112012003111A8 (enExample)
CA (1) CA2770211A1 (enExample)
EA (1) EA201270227A1 (enExample)
IL (1) IL217935A0 (enExample)
NZ (1) NZ598622A (enExample)
WO (1) WO2011019732A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2124556T1 (sl) 2006-10-09 2015-01-30 Charleston Laboratories, Inc. Farmacevtske sestave
EP2240022B1 (en) 2008-01-09 2016-12-28 Charleston Laboratories, Inc. Bilayered tablets comprising oxycodone and promethazine
EP3311667A1 (en) 2009-07-08 2018-04-25 Charleston Laboratories, Inc. Pharmaceutical compositions
BR112012003111A8 (pt) 2009-08-10 2017-10-10 Nupathe Inc Métodos para tratar iontoforeticamente náusea e enxaqueca
EP3416618A1 (en) 2016-02-19 2018-12-26 ZP Opco, Inc. Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines
US10179109B2 (en) 2016-03-04 2019-01-15 Charleston Laboratories, Inc. Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
US11660264B2 (en) 2017-08-23 2023-05-30 Emergex USA Corporation Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches
US11660265B2 (en) 2018-06-28 2023-05-30 Emergex USA Corporation Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4856188A (en) * 1984-10-12 1989-08-15 Drug Delivery Systems Inc. Method for making disposable and/or replenishable transdermal drug applicators
US5605536A (en) * 1983-08-18 1997-02-25 Drug Delivery Systems Inc. Transdermal drug applicator and electrodes therefor
US5651768A (en) * 1983-08-18 1997-07-29 Drug Delivery Systems, Inc. Transdermal drug applicator and electrodes therefor
US4822802A (en) * 1987-02-24 1989-04-18 Alza Corporation Method of fentanly administration for postoperative pain relief
US4927408A (en) * 1988-10-03 1990-05-22 Alza Corporation Electrotransport transdermal system
US5207752A (en) * 1990-03-30 1993-05-04 Alza Corporation Iontophoretic drug delivery system with two-stage delivery profile
DE4014913C2 (de) * 1990-05-10 1996-05-15 Lohmann Therapie Syst Lts Miniaturisiertes transdermales therapeutisches System für die Iontophorese
JP3488466B2 (ja) * 1992-06-02 2004-01-19 アルザ・コーポレーション 電気駆動式薬物投与デバイス
US5807571A (en) * 1993-05-06 1998-09-15 Lts Lohmann Therapie-Systeme Gmbh Transdermal therapeutic systems for administering indole serotonin agonists
US5458569A (en) * 1993-06-08 1995-10-17 Becton Dickinson And Company Wearable iontophoresis system
US5533971A (en) * 1993-09-03 1996-07-09 Alza Corporation Reduction of skin irritation during electrotransport
DE69429603T2 (de) * 1993-09-22 2002-08-14 Hisamitsu Pharmaceutical Co., Inc. Iontophoresematrix
US5697896A (en) 1994-12-08 1997-12-16 Alza Corporation Electrotransport delivery device
IE960312A1 (en) * 1995-06-02 1996-12-11 Alza Corp An electrotransport delivery device with voltage boosting¹circuit
US6216033B1 (en) * 1996-05-22 2001-04-10 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
US6425892B2 (en) * 1995-06-05 2002-07-30 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
AU699774B2 (en) * 1995-06-05 1998-12-17 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
US6245347B1 (en) * 1995-07-28 2001-06-12 Zars, Inc. Methods and apparatus for improved administration of pharmaceutically active compounds
US5941843A (en) * 1996-07-12 1999-08-24 Empi, Inc. Iontophoresis electrode
US5882677A (en) * 1997-09-30 1999-03-16 Becton Dickinson And Company Iontophoretic patch with hydrogel reservoir
SE9802864D0 (sv) * 1998-08-27 1998-08-27 Pharmacia & Upjohn Ab Transdermally administered tolterodine as antimuscarinic agent for the treatment of overactive bladder
US6421561B1 (en) * 1999-12-30 2002-07-16 Birch Point Medical, Inc. Rate adjustable drug delivery system
IT1319210B1 (it) * 2000-10-13 2003-09-26 Italiano Biochimico Lisapharma Pellicola per la somministrazione dermica e transdermica di principiattivi.
US6653014B2 (en) * 2001-05-30 2003-11-25 Birch Point Medical, Inc. Power sources for iontophoretic drug delivery systems
EP1435945B1 (en) * 2001-06-05 2008-08-13 Aung-din, Ronald Topical migraine therapy
CA2512854C (en) * 2002-06-28 2010-02-09 Alza Corporation A reservoir for use in electrotransport drug delivery
US6745071B1 (en) * 2003-02-21 2004-06-01 Birch Point Medical, Inc. Iontophoretic drug delivery system
RU2326893C2 (ru) * 2003-04-16 2008-06-20 Кориум Интернэшнл Ковалентное и нековалентное сшивание гидрофильных полимеров и адгезивные композиции, полученные с ними
US8734421B2 (en) * 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity
US20050228336A1 (en) * 2004-04-07 2005-10-13 Preston Keusch Electrically assisted lidocaine and epinephrine delivery device having extended shelf-stability
US7856263B2 (en) * 2005-04-22 2010-12-21 Travanti Pharma Inc. Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis
JP2009509685A (ja) * 2005-09-30 2009-03-12 Ｔｔｉ・エルビュー株式会社 損傷組織の治癒を増強するための血管新生因子の送達のためのイオントフォレーシス装置及び方法
US20070093788A1 (en) * 2005-09-30 2007-04-26 Darrick Carter Iontophoresis method and apparatus for systemic delivery of active agents
CA2935569A1 (en) * 2006-04-13 2007-10-25 Teva Pharmaceuticals International Gmbh Transdermal methods and systems for the delivery of anti-migraine compounds
US8366600B2 (en) * 2008-06-19 2013-02-05 Nupathe Inc. Polyamine enhanced formulations for triptan compound iontophoresis
US8155737B2 (en) 2008-06-19 2012-04-10 Nupathe, Inc. Pharmacokinetics of iontophoretic sumatriptan administration
BR112012003111A8 (pt) 2009-08-10 2017-10-10 Nupathe Inc Métodos para tratar iontoforeticamente náusea e enxaqueca

Similar Documents

Publication Publication Date Title
JP2013501796A5 (enExample)
WO2011014255A8 (en) Treatment of crohn's disease with laquinimod
WO2011041478A8 (en) Hematopoietic stem cells for use in the treatment of a kidney injury
WO2008061625A3 (de) Transdermales therapeutisches system zur verabreichung des wirkstoffs buprenorphin
RU2015107877A (ru) Способы лечения болезни альцгеймера и фармацевтические композиции
MX362626B (es) Métodos para tratar pacientes pediátricos usando dexmedetomidina..
JP2010059183A5 (enExample)
JP2013522303A5 (enExample)
JP2016535795A5 (enExample)
MX2012007052A (es) Metodo para tratar fibrilacion atrial.
EA200802412A1 (ru) Терапевтические комбинации для сопровождающихся болью медицинских состояний
RU2014150942A (ru) Лечение побочных эффектов в виде моторных и двигательных расстройств, связанных с лечением болезни паркинсона
WO2012050831A3 (en) Combination treatment for dermatological conditions
NZ598622A (en) Methods for iontophoretically treating nausea and migraine
RU2009122281A (ru) Средство для лечения заболеваний в ветеринарии на основе соли фосфония
JP2012525358A5 (enExample)
JP2011500589A5 (enExample)
RU2009127776A (ru) Профилактическое или терапевтическое средство от алопеции
WO2014047288A3 (en) Transglutaminase tg2 inhibitors, pharmaceutical compositions, and methods of use thereof
MX2012002161A (es) El uso de lapatinib o una sal o composición farmacéuticamente aceptable del mismo para el tratamiento de cancer.
PL1732551T3 (pl) Perheksylina do leczenia przewlekłej niewydolności serca
RU2010154623A (ru) Производные 1-аминоалкилциклогексана для лечения расстройств сна
JP2013502449A5 (enExample)
WO2011008490A3 (en) Combination therapies for the treatment of obesity
RU2012114097A (ru) Терапевтический агент против хронической боли